Oyen WJ - Search Results

1

The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.

Dijkman BG, Schuurbiers OC, Vriens D, Looijen-Salamon M, Bussink J, Timmer-Bonte JN, Snoeren MM, Oyen WJ, van der Heijden HF, de Geus-Oei LF. Dijkman BG, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2037-47. doi: 10.1007/s00259-010-1505-2. Epub 2010 Jun 10. Eur J Nucl Med Mol Imaging. 2010. PMID: 20533031 Free PMC article.

2

Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.

Oyen WJ, Mudde AH, van den Broek WJ, Corstens FH. Oyen WJ, et al. J Nucl Med. 1995 Apr;36(4):613-5. J Nucl Med. 1995. PMID: 7699452 Free article.

3

Acute myelofibrosis mimicking multiple bone metastases on Tc-99m MDP bone imaging.

Oyen WJ, Raemaekers JM, Corstens FH. Oyen WJ, et al. Clin Nucl Med. 1998 Jan;23(1):1-2. doi: 10.1097/00003072-199801000-00001. Clin Nucl Med. 1998. PMID: 9442954

4

Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.

Drenth JP, Nagengast FM, Oyen WJ. Drenth JP, et al. Among authors: oyen wj. Eur J Nucl Med. 2001 Dec;28(12):1766-9. doi: 10.1007/s002590100645. Epub 2001 Oct 19. Eur J Nucl Med. 2001. PMID: 11734913

5

131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.

Brouwers AH, Dorr U, Lang O, Boerman OC, Oyen WJ, Steffens MG, Oosterwijk E, Mergenthaler HG, Bihl H, Corstens FH. Brouwers AH, et al. Among authors: oyen wj. Nucl Med Commun. 2002 Mar;23(3):229-36. doi: 10.1097/00006231-200203000-00005. Nucl Med Commun. 2002. PMID: 11891480 Clinical Trial.

6

The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.

Spermon JR, De Geus-Oei LF, Kiemeney LA, Witjes JA, Oyen WJ. Spermon JR, et al. Among authors: oyen wj. BJU Int. 2002 Apr;89(6):549-56. doi: 10.1046/j.1464-410x.2002.02641.x. BJU Int. 2002. PMID: 11942962

7

Fluorinated amino acids for tumour imaging with positron emission tomography.

Laverman P, Boerman OC, Corstens FH, Oyen WJ. Laverman P, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2002 May;29(5):681-90. doi: 10.1007/s00259-001-0716-y. Epub 2002 Jan 11. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976809 Review.

8

Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.

Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ. Langenhoff BS, et al. Among authors: oyen wj. J Clin Oncol. 2002 Nov 15;20(22):4453-8. doi: 10.1200/JCO.2002.12.134. J Clin Oncol. 2002. PMID: 12431968

9

Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.

Havenga K, Cobben DC, Oyen WJ, Nienhuijs S, Hoekstra HJ, Ruers TJ, Wobbes T. Havenga K, et al. Among authors: oyen wj. Eur J Surg Oncol. 2003 Oct;29(8):662-4. doi: 10.1016/s0748-7983(03)00147-1. Eur J Surg Oncol. 2003. PMID: 14511614

10

Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.

Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Bleeker-Rovers CP, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):29-37. doi: 10.1007/s00259-003-1338-3. Epub 2003 Oct 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 14551752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

688 results

Search Page

Filters